Interpreting cost analyses of clinical interventions

JAMA

Volumn 279, Issue 1, 1998, Pages 54-57

  Balas, E Andrew ^a   Kretschmer, Rainer A C ^c   Gnann, Wolfgang ^c   West, David A ^b   Boren, Suzanne Austin ^a   Centor, Robert M ^d   Nerlich, Michael ^c   Gupta, Mahendra ^e   West, Timothy D ^f   Soderstrom, Naomi S ^g  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f IOWA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; PRIORITY JOURNAL; REVIEW;

EID: 18144448150     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.1.54     Document Type: Review

References (36)

1. Levit KR, Lazenby HC, Cowan CA, Letsch SW. National health expenditures, 1990. Health Care Financing Rev. 1991;13:29-54.
2. Eddy DM. Clinical decision making from theory to practice: what do we do about costs? JAMA. 1990; 264:1161, 1165, 1169-1170.
3. Neumann PJ, Zinner DE, Paltiel AD. The FDA and regulation of cost-effectiveness claims. Health Aff (Millwood). 1996;15(3):54-71.
4. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276:1172-1177.
5. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996; 276:1253-1258.
6. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276:1339-1341.
7. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. Can Med Assoc J. 1996;154:821-831.
8. Stempel DA, Hedblom EC, Durcanin-Robbins JF, Sturm LL. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures. Arch Fam Med. 1996;5:36-40.
9. Dor A, Held PJ, Pauly MV. The Medicare cost of renal dialysis: evidence from statistical cost function. Med Care. 1992;30:879.
10. Taitel MS, Kotses H, Bernstein IL, Bernstein DI, Creer TL. A self-management program for adult asthma, part 2: cost-benefit analysis. J Allergy Clin Immunol. 1995;95:672-676.
11. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analysis in the medical literature. Ann Intern Med. 1992;116:238-244.
12. Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 1993;703:156-163.
13. Robinson R. Economic evaluation and health care: what does it mean? BMJ. 1993;307:670-673.
14. Strauss MJ, Bleecker GC, Steinwald AB. Cost-effectiveness analysis in a changing health care environment. Eur J Cancer. 1993;29A(suppl 7):S3-S5.
15. Spencer DC, Balas EA, Nashelsky JE. Information management. In: Taylor RB, ed. Family Medicine Principles and Practice. 4th ed. New York, NY: Springer-Verlag NY Inc; 1994:1028-1035.
16. Balas EA, Austin SM, Ewigman BG, Brown GD, Mitchell JA. Methods of randomized controlled clinical trials in health services research. Med Care. 1995; 33:687-699.
17. Balas EA, Stockham MG, Mitchell JA, Austin SM, West DA, Ewigman BG. The Columbia Registry of Information and Utilization Management Trials. J Am Med Inform Assoc. 1995;2:307-315.
18. Balas EA, Austin SM, Mitchell JA, Ewigman BG, Bopp KD, Brown GD. The clinical value of computerized information services: a review of 98 randomized clinical trials. Arch Fam Med. 1996;5:271-278.
19. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measurement. 1960;20:37-46.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
21. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981:218.
22. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
23. Atkinson AA, Banker RD, Kaplan RS, Young MS. Management Accounting. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1995.
24. Garrison RH, Noreen EW. Managerial Accounting. 8th ed. Chicago, Ill: Richard D Irwin Inc, a Times-Mirror Higher Education Group Inc Co; 1997:178-199.
25. Cooper R, Kaplan RS. Activity-based systems: measuring the costs of resource usage. Accounting Horizons. 1992;6:1-13.
26. Hughes SL, Cummings J, Weaver F, Manheim LM, Conrad KJ, Nash K. A randomized trial of Veterans Administration home care for severely disabled veterans. Med Care. 1990;28:135-145.
27. Topol EJ, Burek K, O'Neill WW, et al. A randomized controlled trial of hospital discharge 3 days after myocardial infarction in the era of re perfusion. N Engl J Med. 1988;318:1083-1088.
28. Tucker MA, Davison JG, Ogle SJ. Day hospital rehabilitation-effectiveness and cost in the elderly: a randomised controlled trial. BMJ. 1984;289: 1209-1212.
29. Oldridge N, Furlong W, Feeny D, et al. Economic evaluation of cardiac rehabilitation soon after myocardial infarction. Am J Cardiol. 1993;72:154-161.
30. Working Group on Recommendations for Reporting Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature: a position paper. Ann Intern Med. 1994;121:894-895.
31. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA. 1994;272:1926-1931.
32. Rennie D. Reporting randomized controlled trials: an experiment and a call for responses from readers. JAMA. 1995;273:1054-1055.
33. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276: 637-639.
34. Mason J, Drummond M. Reporting guidelines for economic studies. Health Econ. 1995;4:85-94.
35. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the British Medical Journal: the BMJ Economic Evaluation Working Party. BMJ. 1996;313: 275-283.
36. Oddone E, Weinberger M, Hurder A, Henderson W, Simel D. Measuring activities in clinical trials using random work sampling: implications for cost-effectiveness analysis and measurement of the intervention. J Clin Epidemiol. 1995;48:1011-1018.